E-LIB Suche - Ergebnisse für: Wei, Haijing

1

Diversity of evolution in MDR monophasic S. Typhimurium amo..:

Zhao, Qiu-Yun ; Zhang, Lin ; Yang, Jin-Tao...
International Journal of Food Microbiology. 412 (2024) - p. 110572 , 2024

Link: https://doi.org/10.1016/..

2

Adaptive evolution in asymptomatic host confers MDR Salmone..:

He, Bing ; Zhu, Ting-ting ; Liang, Yin...
Science of The Total Environment. 908 (2024) - p. 168340 , 2024

Link: https://doi.org/10.1016/..

3

Clinical utility of six serum tumor markers for the diagnos..:

Yang, Yongchang ; Chang, Shuai ; Wang, Na...
iLABMED. 1 (2023) 2 - p. 132-141 , 2023

Link: https://doi.org/10.1002/..

4

A Phase I Clinical Study Comparing the Tolerance, Immunogen..:

Zhang, Hong ; Wang, Hong ; Wei, Haijing...
Frontiers in Pharmacology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

5

First-in-Human, Double-Blind, Randomized, Placebo-Controlle..:

Liu, Jingrui ; Zhu, Xiaoxue ; Zhang, Hong...
Frontiers in Pharmacology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

6

A Phase I, Randomized, Single-Dose Study to Evaluate the Bi..:

Zhang, Hong ; Chen, Hong ; Li, Xiaojiao...
Frontiers in Pharmacology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

7

Impacts of CYP2C19 genetic polymorphisms on bioavailability..:

Zhang, Yifan ; Zhu, Xiaoxue ; Zhan, Yan...
British Journal of Clinical Pharmacology. 86 (2020) 9 - p. 1860-1874 , 2020

Link: https://doi.org/10.1111/..

8

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Si..:

Liu, Jingrui ; Lv, Binhua ; Yin, Hewen...
Frontiers in Pharmacology. 11 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

9

A phase I, randomized, double-blinded, single-dose study ev..:

Zhang, Hong ; Zhu, Xiaoxue ; Wei, Haijing...
Int. Journal of Clinical Pharmacology and Therapeutics. 57 (2019) 3 - p. 167-174 , 2019

Link: https://doi.org/10.5414/..

10

Evaluation of Tolerability, Pharmacokinetics and Pharmacody..:

Li, Xiaojiao ; Liu, Cai ; Zhu, Xiaoxue...
Frontiers in Pharmacology. 9 (2018) - p. , 2018

Link: https://doi.org/10.3389/..

11

Tolerance, variability, and pharmacokinetics of bevacizumab..:

Zhang, Hong ; Li, Qingmei ; Zhu, Xiaoxue...
Cancer Chemotherapy and Pharmacology. 82 (2018) 4 - p. 615-623 , 2018

Link: https://doi.org/10.1007/..

12

A Phase I, Randomized, Single-Dose Study to Evaluate the Bi..:

Zhang, Hong ; Chen, Hong ; Li, Xiaojiao...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190825/. , 2021

Link: http://www.ncbi.nlm.nih...

13

A Phase I Clinical Study Comparing the Tolerance, Immunogen..:

Zhang, Hong ; Wang, Hong ; Wei, Haijing...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868548/. , 2021

Link: http://www.ncbi.nlm.nih...

14

First-in-Human, Double-Blind, Randomized, Placebo-Controlle..:

Liu, Jingrui ; Zhu, Xiaoxue ; Zhang, Hong...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339258/. , 2021

Link: http://www.ncbi.nlm.nih...

15

Impacts of CYP2C19 genetic polymorphisms on bioavailability..:

Zhang, Yifan ; Zhu, Xiaoxue ; Zhan, Yan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444798/. , 2020

Link: http://www.ncbi.nlm.nih...